Cargando…
Genomic characterization and outcome evaluation of kinome fusions in lung cancer revealed novel druggable fusions
Kinase fusions represent an important type of somatic alterations that promote oncogenesis and serve as diagnostic markers in lung cancer. We aimed to identify the landscape of clinically relevant kinase fusions in Chinese lung cancer and to explore rare kinase rearrangements; thus, providing valuab...
Autores principales: | Li, Binghao, Qu, Hao, Zhang, Jing, Pan, Weibo, Liu, Meng, Yan, Xiaobo, Huang, Xin, He, Xuexin, Lin, Dong, Liu, Sisi, Guan, Ruting, Wu, Yong, Ou, Qiuxiang, Bao, Hua, Xu, Youbin, Wu, Xue, Shao, Yang, Lin, Nong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8433182/ https://www.ncbi.nlm.nih.gov/pubmed/34508169 http://dx.doi.org/10.1038/s41698-021-00221-z |
Ejemplares similares
-
Kinome profiling of cholangiocarcinoma organoids reveals potential druggable targets that hold promise for treatment stratification
por: Lieshout, Ruby, et al.
Publicado: (2022) -
A kinome-wide RNAi screen identifies ERK2 as a druggable regulator of Shank3 stability
por: Wang, Li, et al.
Publicado: (2019) -
The fusion landscape of hepatocellular carcinoma
por: Zhu, Chengpei, et al.
Publicado: (2019) -
Kinome Reprogramming Is a Targetable Vulnerability in ESR1 Fusion-Driven Breast Cancer
por: Gou, Xuxu, et al.
Publicado: (2023) -
The rationale for druggability of CCDC6-tyrosine kinase fusions in lung cancer
por: Cerrato, Aniello, et al.
Publicado: (2018)